SHSE:600993'
s OCF Margin % Range Over the Past 10 Years
Min: 9.68 Med: 14.78 Max: 20.35
Current: 17.54
During the past 13 years, the highest OCF Margin % of Mayinglong Pharmaceutical Group Co was 20.35%. The lowest was 9.68%. And the median was 14.78%.
SHSE:600993's OCF Margin % is ranked better than 72.2% of 964
companies
in the Drug Manufacturers industry
Industry Median: 10.035
vs SHSE:600993: 17.54
Mayinglong Pharmaceutical Group Co OCF Margin % Related Terms
Mayinglong Pharmaceutical Group Co OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mayinglong Pharmaceutical Group Co OCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Mayinglong Pharmaceutical Group Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mayinglong Pharmaceutical Group Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mayinglong Pharmaceutical Group Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Mayinglong Pharmaceutical Group Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mayinglong Pharmaceutical Group Co (SHSE:600993) has a OCF Margin % of 23.58% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Mayinglong Pharmaceutical Group Co and its competitors. This is 60% above median its historical median of 14.78. Over the past decade, Mayinglong Pharmaceutical Group Co's OCF Margin % has ranged from 9.68 to 20.35. According to the industry distribution chart, Mayinglong Pharmaceutical Group Co ranks #268 out of 964 companies in the Drug Manufacturers industry, placing it in the top 27.8%.
Is Mayinglong Pharmaceutical Group Co's OCF Margin % too high?
Mayinglong Pharmaceutical Group Co's current OCF Margin % of 23.58% is 60% above median its 10-year median of 14.78. Over the past 10 years, this metric has ranged from a low of 9.68 to a high of 20.35. The Drug Manufacturers industry median OCF Margin % is 10.04. Mayinglong Pharmaceutical Group Co's value of 23.58% is 135% above this industry median. Based on the distribution chart, Mayinglong Pharmaceutical Group Co ranks #268 out of 964 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Mayinglong Pharmaceutical Group Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mayinglong Pharmaceutical Group Co's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Mayinglong Pharmaceutical Group Co ranks #268 out of 964 companies for OCF Margin %. This puts Mayinglong Pharmaceutical Group Co in the upper half of its industry. The industry median OCF Margin % is 10.04. Mayinglong Pharmaceutical Group Co's value of 23.58% is 135% above this benchmark. Historically, Mayinglong Pharmaceutical Group Co's own OCF Margin % has ranged from 9.68 to 20.35 over the past decade. While the company's 10-year median is 14.78 vs. the industry median of 10.04, Mayinglong Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mayinglong Pharmaceutical Group Co's current OCF Margin % of 23.58% is 135% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Mayinglong Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mayinglong Pharmaceutical Group Co's current OCF Margin % is 23.58%, which is 60% above median its own 10-year median of 14.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mayinglong Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Mayinglong Pharmaceutical Group Co (SHSE:600993) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥29.53, compared to a current price of ¥23.25 — trading 21.3% below its estimated fair value. The current OCF Margin % is 23.58%, which is 60% above median its 10-year median of 14.78 and 135% above the Drug Manufacturers industry median of 10.04. Mayinglong Pharmaceutical Group Co's overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Mayinglong Pharmaceutical Group Co (SHSE:600993), the current OCF Margin % is 23.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mayinglong Pharmaceutical Group Co (SHSE:600993) Overvalued in 2026?
Based on GuruFocus' analysis, Mayinglong Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥23.25 is trading 21.3% below its estimated GF Value™ of ¥29.53.
GuruFocus considers Mayinglong Pharmaceutical Group Co to be Modestly Undervalued.
Key valuation signals for SHSE:600993:
OCF Margin %: 23.58% (60% above median its 10-year median of 14.78)
GF Value™: ¥29.53 vs. price of ¥23.25 (21.3% below fair value)
Industry Position: 135% above the Drug Manufacturers median (#268 of 964)
No single metric tells the full story. See the SHSE:600993 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mayinglong Pharmaceutical Group Co Business Description
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly involved in pharmaceutical development, retailing and wholesaling. The company provides ointments, suppositories, and tablets for hemorrhoids.
92GF Score
Get the complete analysis for SHSE:600993
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600993 has been successfully added to your 
